These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical effectiveness of anticoagulation therapy among older patients with heart failure and without atrial fibrillation: findings from the ADHERE registry linked to Medicare claims. Hernandez AF; Hammill BG; Kociol RD; Eapen ZJ; Fonarow GC; Klaskala W; Mills RM; Curtis LH J Card Fail; 2013 Jun; 19(6):401-7. PubMed ID: 23743489 [TBL] [Abstract][Full Text] [Related]
6. Sex-Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation. Palamaner Subash Shantha G; Mentias A; Inampudi C; Kumar AA; Chaikriangkrai K; Bhise V; Deshmukh A; Patel N; Pancholy S; Horwitz PA; Mickelsen S; Bhave PD; Giudici M; Oral H; Vaughan Sarrazin MS J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862952 [TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®. Ghanbari H; Nallamothu BK; Wang Y; Curtis JP J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637345 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims. Kociol RD; Hammill BG; Hernandez AF; Klaskala W; Mills RM; Curtis LH; Fonarow GC Clin Cardiol; 2011 Nov; 34(11):682-8. PubMed ID: 22057910 [TBL] [Abstract][Full Text] [Related]
9. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden. Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277 [TBL] [Abstract][Full Text] [Related]
10. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776 [TBL] [Abstract][Full Text] [Related]
11. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort. Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164 [TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814 [TBL] [Abstract][Full Text] [Related]
15. Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation. Eapen ZJ; Mi X; Qualls LG; Hammill BG; Fonarow GC; Turakhia MP; Heidenreich PA; Peterson ED; Curtis LH; Hernandez AF; Al-Khatib SM J Card Fail; 2014 Jan; 20(1):23-30. PubMed ID: 24275703 [TBL] [Abstract][Full Text] [Related]
16. Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study. Genovesi S; Rebora P; Gallieni M; Stella A; Badiali F; Conte F; Pasquali S; Bertoli S; Ondei P; Bonforte G; Pozzi C; Rossi E; Valsecchi MG; Santoro A J Nephrol; 2017 Aug; 30(4):573-581. PubMed ID: 27834042 [TBL] [Abstract][Full Text] [Related]
17. Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery. Wiggins NB; Chong DT; Houghtaling PL; Hussein AA; Saliba W; Sabik JF; Wazni O; Wilkoff BL; Tarakji KG Europace; 2017 Aug; 19(8):1335-1342. PubMed ID: 27738074 [TBL] [Abstract][Full Text] [Related]
18. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442 [TBL] [Abstract][Full Text] [Related]
19. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283 [TBL] [Abstract][Full Text] [Related]
20. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin. Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]